AstraZeneca Q3 Profit Beats Estimates as Cancer Drug Sales Drive Growth

Summary

AstraZeneca's third-quarter profit beat analyst estimates, with growth driven by sales of its cancer drugs, according to a Seeking Alpha headline published October 30, 2026. A Seeking Alpha preview of the same Q3 earnings was published the previous day, October 29, 2026. Both items were available only as headlines with no summary text, so this report includes no figures, analyst expectations, or other details about the results.

Timeline

1. Seeking Alpha

   29 Oct 2026, 14:27 UTCSource ↗

   Seeking Alpha published a breaking news item on October 29, 2026, previewing AstraZeneca's Q3 earnings; the item has no summary text.

2. Seeking Alpha

   30 Oct 2026, 08:57 UTCSource ↗

   Seeking Alpha reported in a breaking news item on October 30, 2026, that AstraZeneca's Q3 profit beat estimates as cancer drug sales drove growth; the item has no summary text.